SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Amphastar Pharmaceuticals Q1 Adj. EPS $0.170 Beats $0.080 Estimate, Sales $84.688M Beat $82.830M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.170 per share which beat the analyst consensus estimate of $0.080 by 112.5 percent. This is a 70 percent increase over earnings of $0.100 per

Benzinga · 05/07/2020 20:27

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.170 per share which beat the analyst consensus estimate of $0.080 by 112.5 percent. This is a 70 percent increase over earnings of $0.100 per share from the same period last year. The company reported quarterly sales of $84.688 million which beat the analyst consensus estimate of $82.830 million by 2.24 percent. This is a 6.14 percent increase over sales of $79.790 million the same period last year.